Nanjing King-Friend Biochemical PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 4/6
Nanjing King-Friend Biochemical PharmaceuticalLtd has a total shareholder equity of CN¥6.0B and total debt of CN¥2.7B, which brings its debt-to-equity ratio to 45.4%. Its total assets and total liabilities are CN¥9.6B and CN¥3.7B respectively.
Key information
45.4%
Debt to equity ratio
CN¥2.72b
Debt
Interest coverage ratio | n/a |
Cash | CN¥2.16b |
Equity | CN¥5.98b |
Total liabilities | CN¥3.66b |
Total assets | CN¥9.64b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 603707's short term assets (CN¥7.4B) exceed its short term liabilities (CN¥3.0B).
Long Term Liabilities: 603707's short term assets (CN¥7.4B) exceed its long term liabilities (CN¥638.7M).
Debt to Equity History and Analysis
Debt Level: 603707's net debt to equity ratio (9.4%) is considered satisfactory.
Reducing Debt: 603707's debt to equity ratio has increased from 15.9% to 45.4% over the past 5 years.
Debt Coverage: 603707's debt is well covered by operating cash flow (62.5%).
Interest Coverage: Insufficient data to determine if 603707's interest payments on its debt are well covered by EBIT.